Background and objective Alzheimer's disease (AD) is a progressive neurodegenerative
disease characterized by declining cognitive ability. Currently, there are no effective …

With rapid aging of the population worldwide, the number of people with dementia is
dramatically increasing. Some studies have emphasized that metabolic syndrome, which …

The present work deals with the green synthesis and characterization of silver nanoparticles
(AgNPs) using Allium cepa (yellowish peel) and the evaluation of its antimicrobial …

Alzheimer's disease (AD) is characterized as a distinct onset and progression of cognitive
and functional decline associated with age, as well as a specific neuropathology. It has been …

Dementia is a growing public health concern, with an estimated prevalence of 57 million
adults worldwide. Alzheimer's disease (AD) accounts for 60–80% of the cases. Clinical trials …

Alzheimer's disease (AD) is a neurodegenerative disease mainly characterized by
progressive cognitive dysfunction and memory impairment. Recent studies have shown that …

Alzheimer's disease (AD) is a progressive neurodegenerative disease for which there is a
lack of effective therapeutic drugs. There is great potential for natural products to be used in …

The use of medicinal plants has grown in popularity in recent decades because, as natural
ingredients, they have fewer adverse effects and are more effective than synthetic …

Wnt/β-catenin (WβC) signaling pathway is an important signaling pathway for the
maintenance of cellular homeostasis from the embryonic developmental stages to …

One of the most complex and challenging developments at the beginning of the third
millennium is the alarming increase in demographic aging, mainly—but not exclusively …